Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1995
Buy Report Download FREE Resources

Published: November 09, 2022 Report Code: GDHC0039CHR-ST

Select Item

Argentina Healthcare (Pharma and Medical Devices) Market Report Overview

The Argentina pharmaceutical market size was $4.7 billion in 2020 and is expected to decline at a negative CAGR of more than 8% during 2020-2025. The medical devices market size in Argentina was valued at $5.8 billion in 2021 and is expected to achieve a CAGR of more than 1% during 2022-2027. The Argentine Ministry of Health (MinSalud) approved the “Plan for the Development of Pharmaceutical Services Based on Primary Health Care” in 2021, to support and grade the steps taken by pharmacy professionals for the health and quality of life needs of the population.

Argentina Pharmaceutical Market Overview 2020-2025 ($ Billion)

Argentina Pharmaceutical Market Overview 2020-2025 ($ Billion)

Buy the Full Report to Gain More Information on the Argentina Pharmaceutical Market Forecast, Download A Free Report Sample

Market Size (2020) $4.7 billion
CAGR (2020-2025)  <(8)%
Key Segments Generics, Biologics, Biosimilars, and Over-the-Counter (OTC) Medicines
Key Import Partners China, Brazil, the US, Paraguay, and Germany
Key Export Partners Uruguay, Brazil, the US, Mexico, and Paraguay
Leading Players Pfizer, Sanofi, Bayer AG, GlaxoSmithKline (GSK), and Roemmers SAICF
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

The Argentina healthcare market research report is an essential source of information on the analysis of the healthcare, regulatory, and reimbursement landscape in Argentina. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

Argentina Medical Devices Market Overview 2021-2027 ($ Billion)

Argentina Medical Devices Market Overview 2021-2027 ($ Billion)

Buy the Full Report to Gain More Information On the Argentina Medical Devices Market Forecast, Download A Free Report Sample

Market Size (2021) $5.8 billion
CAGR (2022-2027)  >1%
Key Segments Hospital Supplies, Cardiovascular Devices, General Surgery Devices, Orthopedic Devices, and Anesthesia & Respiratory Devices
Leading Players Abbott, Fresenius SE & Co. KGaA (Fresenius), GE Healthcare, Terumo, and Coloplast
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Argentina Pharmaceuticals Market Segmentation by Import and Export Partners

The key import partners of Argentina are China, Brazil, the US, Paraguay, and Germany, among others. China accounts for the highest percentage of the import business. The key export partners of Argentina are Uruguay, Brazil, the US, Mexico, and Paraguay, among others. Uruguay accounts for the highest percentage of the export business.

Argentina Pharmaceuticals Market Analysis by Import Partners

Argentina Pharmaceuticals Market Analysis by Import Partners

Buy the Full  Report for More Import Partner Insights into the Argentina Pharmaceuticals Market, Download A Free Report Sample

Argentina Pharmaceuticals Market Analysis by Export Partners

Argentina Pharmaceuticals Market Analysis by Export Partners

Buy the Full Report for More Export Partner Insights into the Argentina Pharmaceuticals Market, Download A Free Report Sample

Argentina Pharmaceuticals Market Segments

The key segments in the Argentina pharmaceuticals market are generics, biologics, biosimilars, and over-the-counter (OTC) medicines.

Argentina Medical Devices Market Segments

The key segments in the Argentina medical devices market are hospital supplies, cardiovascular devices, general surgery devices, orthopedic devices, and anesthesia & respiratory devices. In 2021, hospital supplies had the highest share of Argentina’s medical devices market.

Argentina Medical Devices Market Analysis by Segments, 2021 (%)

Argentina Medical Devices Market Analysis by Segments, 2021 (%)

Buy the Full Report for More Segment Insights Into The Argentina Medical Devices Market, Download a Free Report Sample

Argentina Pharmaceuticals Market – Competitive Landscape

The leading players in the Argentina pharmaceuticals market are Pfizer, Sanofi, Bayer AG, GlaxoSmithKline (GSK), and Roemmers SAICF.

Argentina Pharmaceuticals Market Analysis by Players

Argentina Pharmaceuticals Market Analysis by Players

Buy the Full Report to Know More About Leading Players In The Argentina Pharmaceuticals Market, Download A Free Report Sample

Argentina Medical Devices Market – Competitive Landscape

The major players in the medical devices market of Argentina are Abbott, Fresenius SE & Co. KGaA (Fresenius), GE Healthcare, Terumo, and Coloplast.

Argentina Medical Devices Market Analysis by Players

Argentina Medical Devices Market Analysis by Players

Buy the Full Report to Know More About Leading Players in the Argentina Medical Devices Market, Download A Free Report Sample

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Argentina, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.

  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, Bayer, GlaxoSmithKline (GSK), and Roemmers.

  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, Fresenius, GE Healthcare, Terumo, and Coloplast.

  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.

  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.

  • An overview of the opportunities for and challenges to growth in the Argentine healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market

  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the Indonesian healthcare market in the future

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents

1.1 List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights: Facts About the Argentine Healthcare Market

2.3 Key Highlights: Healthcare Startups in Argentina

2.4 Key Events: Argentine Healthcare Timeline, 2016–22

2.5 Key Events: Argentine Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2021–22

2.7 Key Events: Top Completed Deals by Value, 2022

2.8 Country Profile, Argentina, 2021

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Argentina

3.5 Pharmaceutical Market – Medical Tourism, Argentina

3.6 Pharmaceutical Market – Market Segments

3.7 Pharmaceutical Market – Market Segments, Generics, Argentina

3.8 Pharmaceutical Market – Market Segments, Biologics and Biosimilars, Argentina

3.9 Pharmaceutical Market – Market Segment, Over-the-Counter Medicines, Argentina

3.10 Major Therapeutic Areas, Argentina

3.11 COVID-19 Epidemiology, Argentina

3.12 COVID-19 Impact and Developments in the Healthcare Market, Argentina

3.13 COVID-19 Clinical Trials Landscape, Argentina

3.14 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Argentina, 2020–22

6.2 Deal Analysis: Medical Device Market, Argentina, 2020–22

7. Healthtech Landscape

7.1 Healthtech Landscape, Argentina

7.2 Key Healthtech Deals, Argentina

7.3 Adoption of Technology in Healthcare, Argentina

7.4 Digital Healthcare Regulations, Argentina

7.5 Healthtech Landscape: Benefits and Risks, Argentina

8. Market Access

8.1 Overview of Healthcare System, Argentina

8.2 Reimbursement Landscape, Argentina

8.3 Overview of Insurance Providers, Argentina

8.4 Healthcare Spending and Prescription Drug Price Trend, Argentina

8.5 Pricing Policies, Argentina

8.6 Market Access Timeline, Argentina, 2011–22

8.7 Regulatory Landscape, Argentina

8.7.1 Marketing Authorization for Pharmaceutical Products, Argentina

8.7.2 Marketing Authorization for Biologics, Argentina

8.7.3 Marketing Authorization for Medical Devices, Argentina

8.7.4 Intellectual Property Rights, Patents, Argentina

8.7.5 Intellectual Property Rights, Trademarks, Argentina

8.7.6 Clinical Trial Regulation Process, Argentina

8.7.7 Pharmaceutical Clinical Trials Landscape, Argentina

8.7.8 Medical Devices Clinical Trials Landscape, Argentina

8.7.9 Pharmaceutical Import and Export, Argentina

8.7.10 Pharmaceutical Advertising Regulations, Argentina

8.7.11 Pharmacy Regulations, Argentina

8.7.12 Labeling and Packaging Regulations, Argentina

9. Country Healthcare Landscape

9.1 Argentina Healthcare Policy Highlights

9.2 Healthcare Resources and Healthcare Personnel, Argentina

9.3 Life Expectancy and Immunization Rate, Argentina

9.4 Environmental Health, Argentina

9.5 Disease Burden, Argentina

9.6 Healthcare Expenditure, Argentina

10 Trade Associations, Argentina

11 Trade Fairs, Argentina

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: Research and development investment in pharmaceutical market, Argentina, 2022

Table 2: Cost comparison of treatments in the US and Argentina, 2017

Table 3: ANMAT-approved biomimics, Argentina, 2022

Table 4: ANMAT-approved biosimilars, Argentina, 2022

Table 5: Comparison of 12 highest-selling OTC drugs, Argentina, 2021–22

Table 6: Comparison of the most sold drugs, Argentina, 2019–20

Table 7: COVID-19 indicators (number of cases), Global and Argentina, 2022

Table 8: COVID-19-related travel restrictions, Argentina, 2020–22

Table 9: Approved COVID-19 vaccines, Argentina, 2022

Table 10: Target population to be vaccinated with COVID-19 vaccine as per the updated guideline, Argentina, 2021

Table 11: COVID-19 vaccine interchangeability scheme, Argentina, 2021

Table 12: Approved additional and booster COVID-19 vaccines, Argentina, 2021

Table 13: Medical devices market, major segments ($M), Argentina, 2021

Table 14: Copayment values, Argentina, 2022

Table 15: Patent approval fees, Argentina, 2022

Table 16: Trademark fees, Argentina, 2022

Table 17: Trade fairs, Argentina, 2022

Figures

Figure 1: Pharmaceutical market, revenue [ARS ($B), $B], Argentina, 2017–21

Figure 2: Medical devices market, revenue ($B), Argentina, 2016–21

Figure 3: Healthcare start-ups in Argentina, 2022

Figure 4: Country profile, Argentina, 2021

Figure 5: Pharmaceutical market, revenue [ARS ($B), $B], Argentina, 2017–21

Figure 6: Pharmaceutical market, revenue forecast [ARS ($B), $B], Argentina, 2022–27

Figure 7: Pharmaceutical exports ($M), Argentina, 2014–21

Figure 8: Top export partners, Argentina, 2021

Figure 9: Pharmaceutical imports ($B), Argentina, 2014–21

Figure 10: Top import partners, Argentina, 2021

Figure 11: Pharmaceutical supply channel, Argentina, 2022

Figure 12: Major local manufacturers on the basis of revenue ($M), Argentina, 2020

Figure 13: Facilitators associated with the Argentine Medical Tourism Chamber, Argentina, 2022

Figure 14: Hospitals and clinics associated with the Argentine Medical Tourism Chamber, Argentina, 2022

Figure 15: Top treatments offered in Argentina, 2022

Figure 16: Major generic producing pharmaceutical companies, Argentina, 2022

Figure 17: OTC market revenue ($B), Argentina, 2013–21

Figure 18: OTC medicines market ($M), major categories, Argentina, 2021

Figure 19: Top five therapeutic areas by annual revenue (%), Argentina, 2020

Figure 20: COVID-19 cases, Argentina, 2020–22

Figure 21: COVID-19 deaths, Argentina, 2020–22

Figure 22: COVID-19 stringency index (based on the share of people who are vaccinated), Argentina, 2020–22

Figure 23: COVID-19 containment and health index, Argentina, 2020–22

Figure 24: COVID-19 fiscal stimulus timeline, Argentina, 2020–22

Figure 25: Vaccination plan as per the strategic plan for vaccination, Argentina, 2020

Figure 26: COVID-19 vaccine doses administration – number of vaccine doses administered, Argentina, 2020–22

Figure 27: Approved additional and booster COVID-19 vaccines, Argentina, 2021

Figure 28: COVID-19 clinical trials count by trial status, Argentina, 2021–22

Figure 29: COVID-19 clinical trials count by trial phase, Argentina, 2021–22

Figure 30: Top COVID-19 clinical trials sponsors by trial count, Argentina, 2021–22

Figure 31: Medical devices market, revenue ($B), Argentina, 2016–21

Figure 32: Medical devices market, revenue forecast ($B), Argentina, 2022–27

Figure 33: Medical devices market, major segments (%), Argentina, 2021

Figure 34: Hospital supplies market, revenue ($B), Argentina, 2017–27

Figure 35: Cardiovascular devices market, revenue ($M), Argentina, 2017–27

Figure 36: General surgery devices market, revenue ($M), Argentina, 2017–27

Figure 37: Orthopedic devices market, revenue ($M), Argentina, 2017–27

Figure 38: Anesthesia and respiratory devices market, revenue ($M), Argentina, 2017–27

Figure 39: Diagnostic market, revenue ($M), Argentina, 2017–21

Figure 40: Diagnostic market, revenue forecast ($M), Argentina, 2022–27

Figure 41: Medical devices market, revenue ($B) of major companies, Argentina, 2020

Figure 42: Deal value and deal count, pharmaceutical market, Argentina, 2020–22

Figure 43: Deal value and deal count subtypes, pharmaceutical market, Argentina, 2020–22

Figure 44: Deal value and deal count, quarterly, pharmaceutical market, Argentina, 2020–22

Figure 45: Top therapy areas by deal value ($M), pharmaceutical market, Argentina, 2020–22

Figure 46: Top therapy areas by deal count, pharmaceutical market, Argentina, 2020–22

Figure 47: Deal value and deal count, medical devices market, Argentina, 2020–22

Figure 48: Deal value and deal count subtypes, medical devices market, Argentina, 2020–22

Figure 49: Deal value and deal count, quarterly, medical devices market, Argentina, 2020–22

Figure 50: Top equipment sectors by deal value ($M), medical devices market, Argentina, 2020–22

Figure 51: Top equipment sectors by deal count, medical devices market, Argentina, 2020–22

Figure 52: Phases and activities of National Digital Health Strategy, Argentina, 2018–24

Figure 53: Simplified ESB architecture of the National Digital Health Network, Argentina, 2022

Figure 54: Principles of National Digital Health Network, Argentina, 2022

Figure 55: Overview of healthcare system, Argentina, 2022

Figure 56: Medicines covered under the Remediar, Argentina, 2022

Figure 57: Process for accessing medicines through Remediar, Argentina, 2022

Figure 58: Users of National Social Works and EMP, Argentina, 2022

Figure 59: PAMI users, Argentina, 2022

Figure 60: OOP expenditure (% of total expenditure on health), Argentina, 2013–22

Figure 61: Consumer price index (%), health price index, Argentina, 2018–22

Figure 62: Evolution of overall CPI and Health CPI on a monthly basis, Argentina, 2021–22

Figure 63: Organization of ANMAT, Argentina, 2022

Figure 64: Patent approval process, Argentina, 2022

Figure 65: Trademark approval process, Argentina, 2022

Figure 66: Clinical trials approved by the ANMAT according to therapeutic area, Argentina, 2017–19

Figure 67: Pharmaceutical clinical trials count by trial status, Argentina, 2021–22

Figure 68: Pharmaceutical clinical trials count by indication, Argentina, 2021–22

Figure 69: Pharmaceutical clinical trials count by phase, Argentina, 2021–22

Figure 70: Top five pharmaceutical clinical trials sponsors by count, Argentina, 2021–22

Figure 71: Medical device clinical trials count by trial status, Argentina, 2021–22

Figure 72: Medical devices clinical trials count by market categories, Argentina, 2021–22

Figure 73: Medical devices clinical trials count by therapeutic areas, Argentina, 2021–22

Figure 74: Medical devices clinical trials sponsors by count, Argentina, 2021–22

Figure 75: Necessary documentation for import of any medicine for personal use, Argentina, 2022

Figure 76: Drugs labeling, Argentina, 2022

Figure 77: Hospital beds (per 1,000 population), Argentina, 2012–22

Figure 78: Physicians (per 1,000 Population), Argentina, 2013–22

Figure 79: Nurses (per 1,000 population), Argentina, 2013–22

Figure 80: Immunization rate (%), Argentina, 2013–22

Figure 81: Life expectancy at birth (years), Argentina, 2013–22

Figure 82: PM2.5 (µg per m3), Argentina, 2013–22

Figure 83: CO2 emissions (metric tons per capita), Argentina, 2013–22

Figure 84: Major causes of mortality (per 100,000 population), Argentina, 2019

Figure 85: Major causes of male mortality (per 100,000 population), Argentina, 2019

Figure 86: Major causes of female mortality (per 100,000 population), Argentina, 2019

Figure 87: DALYs by major disease (per 100,000 population), Argentina, 2019

Figure 88: Healthcare expenditure as percentage of GDP (%), Argentina, 2013–22

Figure 89: Health expenditure share (% of total health spending), Argentina, 2013–22

Frequently asked questions

Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape standard reports
Currency USD
$1,995

Can be used by individual purchaser only

Most Popular
$2,992

Can be shared by unlimited users within one corporate location e.g. a regional office

$3,990

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Pharmaceuticals reports
Pharmaceuticals
New
Reflux Esophagitis (Gastroesophageal Reflux Disease): Market View, Current and Future…
$3,495 | June 2026
Pharmaceuticals
New
Hepatocellular Carcinoma (HCC): Epidemiology Report and Forecast to 2035
$9,995 | June 2026
Pharmaceuticals
New
Overweight and Obesity: Epidemiology Report and Forecast to 2035
$9,995 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape in real time.

  • Access a live Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more